{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:59:44Z","timestamp":1785333584820,"version":"3.55.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Diabetic Kidney Disease (DKD) is a prevalent complication of uncontrolled hyperglycemia that imposes a considerable burden on the health system due to the need for renal replacement therapy in the long term. Therefore, early diagnosis and prevention of renal damage in diabetic patients is critical. In the present study, we investigated the expression level of Janus kinase (Jak) 1, 2, and 3 genes, which play a role in the signal transduction of inflammatory cytokines and growth factors, for therapeutic or diagnostic purposes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Sixty patients with DKD, 60 diabetic patients without nephropathy, and 60 healthy individuals were recruited, and the expression level of the Jak1, Jak2, and Jak3 genes was evaluated using real-time polymerase chain reaction in peripheral blood mononuclear cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The results showed that Jak1 and Jak2 gene expression was significantly upregulated in DKD patients compared to healthy controls (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      values: 0.02 and 0.002, respectively). A significant negative correlation was observed between the expression of Jak1 and 2 genes and glomerular filtration rate in patients (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      values: 0.047 and 0.03, respectively). There was also a positive correlation between the urine albumin-creatinine ratio of the DKD group with Jak1 and 2 gene expression levels (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      values: 0.008 and 0.015, respectively). Moreover, receiver operating characteristic curve analysis showed a fair diagnostic value for Jak2 expression in DN (0.71, 95% confidence interval: 0.59\u20130.834 [\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002]).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Gene expression evaluation showed an increased expression of Jak1 and Jak2 in DKD, suggesting Jak1\/2 inhibition for the treatment of patients. In addition, Jak2 expression might have diagnostic or predictive value in diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jrms.jrms_680_24","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:02:14Z","timestamp":1785330134000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association of Janus kinase 1 and 2 expression with clinical indices in diabetic kidney disease"],"prefix":"10.4103","volume":"31","author":[{"given":"Mahboobeh","family":"Freidoon","sequence":"first","affiliation":[{"name":"Department of Nephrology, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naghmeh","family":"Sayadi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Assadiasl","sequence":"additional","affiliation":[{"name":"Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Iranian Tissue Bank and Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Kazemzadehghadim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narjes","family":"Soleimanifar","sequence":"additional","affiliation":[{"name":"Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Sadr","sequence":"additional","affiliation":[{"name":"Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanieh","family":"Mojtahedi","sequence":"additional","affiliation":[{"name":"Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ahmadi","sequence":"additional","affiliation":[{"name":"Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Nicknam","sequence":"additional","affiliation":[{"name":"Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4]]},"reference":[{"key":"R1-20260729","doi-asserted-by":"crossref","first-page":"109118","DOI":"10.1016\/j.diabres.2021.109118","article-title":"IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021","volume":"183","author":"Ogurtsova","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"R2-20260729","first-page":"1497449","article-title":"Diabetic nephropathy: Challenges in pathogenesis, diagnosis, and treatment","author":"Samsu","year":"2021","journal-title":"Biomed Res Int 2021"},{"key":"R3-20260729","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.3390\/ijms21113798","article-title":"Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy","volume":"21","author":"Rayego-Mateos","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R4-20260729","doi-asserted-by":"crossref","first-page":"E061123223172","DOI":"10.2174\/0115733998267893231016062205","article-title":"Immunological approaches in the treatment of diabetic nephropathy","volume":"21","author":"Pour-Reza-Gholi","year":"2025","journal-title":"Curr Diabetes Rev"},{"key":"R5-20260729","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/gb-2004-5-12-253","article-title":"The Janus kinases (Jaks)","volume":"5","author":"Yamaoka","year":"2004","journal-title":"Genome Biol"},{"key":"R6-20260729","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2337\/db08-1328","article-title":"Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy","volume":"58","author":"Berthier","year":"2009","journal-title":"Diabetes"},{"key":"R7-20260729","doi-asserted-by":"crossref","first-page":"174121","DOI":"10.1016\/j.ejphar.2021.174121","article-title":"JAK\/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes","volume":"902","author":"Chen","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"R8-20260729","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3390\/ph14070608","article-title":"Early renoprotective effect of ruxolitinib in a rat model of diabetic nephropathy","volume":"14","author":"El-Kady","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"R9-20260729","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/ndt\/gfx377","article-title":"JAK1\/JAK2 inhibition by baricitinib in diabetic kidney disease: Results from a phase 2 randomized controlled clinical trial","volume":"33","author":"Tuttle","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"R10-20260729","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1046\/j.1523-1755.2001.059002702.x","article-title":"Progression of diabetic nephropathy","volume":"59","author":"Hovind","year":"2001","journal-title":"Kidney Int"},{"key":"R11-20260729","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2337\/dci23-0030","article-title":"Diabetic nephropathy: Update on pillars of therapy slowing progression","volume":"46","author":"Naaman","year":"2023","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"R12-20260729","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.14007","article-title":"An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines","volume":"22","author":"Selby","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl 1","key":"R13-20260729","first-page":"S17","article-title":"American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"R14-20260729","doi-asserted-by":"crossref","first-page":"e152711","DOI":"10.5812\/zjrms-144450","article-title":"Upregulated expression of janus kinase genes in T cell-mediated acute kidney allograft rejection","volume":"26","author":"Freidoon","year":"2024","journal-title":"Zahedan J Res Med Sci"},{"key":"R15-20260729","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C (T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"R16-20260729","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"Lancet"},{"key":"R17-20260729","doi-asserted-by":"crossref","first-page":"F762","DOI":"10.1152\/ajprenal.00181.2005","article-title":"Role of the JAK\/STAT signaling pathway in diabetic nephropathy","volume":"290","author":"Marrero","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"R18-20260729","doi-asserted-by":"crossref","first-page":"1233259","DOI":"10.3389\/fcell.2023.1233259","article-title":"JAK\/STAT signaling in diabetic kidney disease","volume":"11","author":"Liu","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"R19-20260729","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/jcph.1874","article-title":"Baricitinib: From rheumatoid arthritis to COVID-19","volume":"61","author":"Assadiasl","year":"2021","journal-title":"J Clin Pharmacol"},{"key":"R20-20260729","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1046\/j.1523-1755.2002.00311.x","article-title":"Angiotensin II activation of the JAK\/STAT pathway in mesangial cells is altered by high glucose","volume":"61","author":"Amiri","year":"2002","journal-title":"Kidney Int"},{"key":"R21-20260729","doi-asserted-by":"crossref","first-page":"F653","DOI":"10.1152\/ajprenal.00163.2003","article-title":"Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli","volume":"286","author":"Banes","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"R22-20260729","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.2337\/diabetes.51.12.3505","article-title":"Inhibition of the Jak\/STAT signaling pathway prevents the high glucose-induced increase in tgf-beta and fibronectin synthesis in mesangial cells","volume":"51","author":"Wang","year":"2002","journal-title":"Diabetes"},{"key":"R23-20260729","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3892\/mmr.2016.5313","article-title":"Melatonin protects podocytes from angiotensin II-induced injury in an in vitro diabetic nephropathy model","volume":"14","author":"Ji","year":"2016","journal-title":"Mol Med Rep"},{"key":"R24-20260729","doi-asserted-by":"crossref","first-page":"140810","DOI":"10.1016\/j.ijbiomac.2025.140810","article-title":"Molecular mechanism and role of miRNA-155 ribonucleic acid in podocyte apoptosis in lupus nephritis: SOCS1 protein expression regulates JAK\/STAT pathway transduction","volume":"304","author":"Pang","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"R25-20260729","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.kint.2018.05.022","article-title":"JAK-STAT signaling is activated in the kidney and peripheral blood cells of patients with focal segmental glomerulosclerosis","volume":"94","author":"Tao","year":"2018","journal-title":"Kidney Int"},{"key":"R26-20260729","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s00125-016-4021-5","article-title":"JAK inhibition in the treatment of diabetic kidney disease","volume":"59","author":"Brosius","year":"2016","journal-title":"Diabetologia"},{"key":"R27-20260729","doi-asserted-by":"crossref","first-page":"10684","DOI":"10.1038\/s41598-025-95952-5","article-title":"MiR-203 improved renal cell injury in diabetic nephropathy by targeting SOCS6\/SOCS7 and inhibiting JAK\/STAT pathway activation","volume":"15","author":"Wang","year":"2025","journal-title":"Sci Rep"},{"key":"R28-20260729","doi-asserted-by":"crossref","first-page":"e70169","DOI":"10.1096\/fj.202401879R","article-title":"CD3D silencing alleviates diabetic nephropathy via inhibition of JAK\/STAT pathway","volume":"38","author":"Lei","year":"2024","journal-title":"FASEB J"}],"container-title":["Journal of Research in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jrms.jrms_680_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:02:18Z","timestamp":1785330138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jrms.jrms_680_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jrms.jrms_680_24","relation":{},"ISSN":["1735-1995","1735-7136"],"issn-type":[{"value":"1735-1995","type":"print"},{"value":"1735-7136","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2024-12-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}